ArticleFrontiers in endocrinology2025
Prognostic significance of stress hyperglycemia ratio in acute coronary syndrome patients with prior coronary artery bypass grafting.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between stress hyperglycemia ratio and acute total occlusion in patients with non-ST-segment elevation myocardial infarction.Frontiers in endocrinology · 2026Observational
- Association Between C-Reactive Protein-Triglyceride Glucose Index and Adverse Cardiovascular Outcomes in Acute Coronary Syndrome Patients With Prior Coronary Artery Bypass Grafting.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with prior coronary artery bypass grafting (CABG) presenting with an acute coronary syndrome (ACS) constitute a subgroup at high cardiovascular risk and have a poor prognosis even after percutaneous coronary intervention (PCI). The stress hyperglycemia ratio (SHR) is a novel marker reflecting acute hyperglycemia adjusted for chronic glycemic status, but its prognostic value in this specific population remains unknown. This study aimed to investigate the association of SHR with long-term adverse cardiovascular outcomes in ACS patients with prior CABG. Methods: The SHR was calculated using the following formula: admission fasting blood glucose (AFBG)/[1.59 × glycosylated hemoglobin A1c (HbA1c) - 2.59]. The primary endpoint was the long-term incidence of major adverse cardiovascular and cerebrovascular events (MACCE), a composite of all-cause death, non-fatal stroke, non-fatal myocardial infarction, or unplanned revascularization. Results: A total of 1,208 ACS patients with prior CABG who underwent PCI were included in the final analysis. During a median follow-up of 1,291 days, 368 (30.5%) patients developed at least one primary endpoint event. Kaplan-Meier analysis revealed a graded, positive relationship between the SHR tertiles and the follow-up incidence of MACCE (log-rank Conclusions: In ACS patients with prior CABG undergoing PCI, an elevated SHR was a strong and independent predictor of long-term MACCE. This simple metric provides potent prognostic information, potentially enhancing risk stratification and guiding management in this high-risk patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.